ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
AbbVie at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
AbbVie brings 2 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 3813. Its program covers the burden and diagnostic delay of axial spondyloarthritis in Latin America. It also covers a head-to-head trial of a JAK inhibitor versus a second TNF inhibitor after one TNF inhibitor fails.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
AbbVie North Chicago, IL | |
Global biopharmaceutical company developing and marketing medicines across several therapeutic areas. | Booth Exhibiting at Booth 3813 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Sun Nov 8 10:30am–12:30pm Industry Mon Nov 9 11:30am–12:15pm Changing Course (48-Week Data Update): Clinical Evidence from the First Head-to-Head Trial Powered to Evaluate Superiority Endpoints at 12 weeks in Patients Switching to a JAKi Versus Another TNFi After a Single TNFi Failure |
Find decision makers at AbbVie
Tell us what you sell and we’ll find the people at AbbVie most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction